Donate to Illuminate Contact TSF
Facebook Logo Twitter Logo Youtube Logo Instagram Logo LinkedIn Logo TikTok Logo Blue Sky Logo

Choose Your Language:

Special Issues

To enhance the dissemination of key research developments related to NMOSD, MOGAD, and other rare neuroimmune conditions, TSF sponsors special issues — collectives of research papers dedicated to these research areas — in highly-respected medical journals. These special issues help bring these rare diseases into the spotlight and encourage researchers to build on the existing body of work.

Neurology Neuroimmunology & Neuroinflammation

Beginning in 2025, TSF is committed to sponsoring the publication fees for up 12 articles for researchers from low to middle income countries (LMICs) in Neurology Neuroimmunology & Neuroinflammation.

Frontiers in Neurology

In 2023, TSF provided $35,000 in support to Frontiers in Neurology to assist authors contributing to “MOGAD: Current Knowledge and Future Trends” by fully or partially covering the article processing charge. To access the entire issue, click here.

Acute Hemorrhagic Leukoencephalitis With Active Hepatitis B Virus Infection: A Case Report

Acute Hemorrhagic Leukoencephalitis With Active Hepatitis B Virus Infection: A Case Report

Show More
Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis

Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis

Show More
Delimiting MOGAD as a disease entity using translational imaging

Delimiting MOGAD as a disease entity using translational imaging

Show More
Epidemiology of MOGAD: A review of prevalence and incidence worldwide

Epidemiology of MOGAD: A review of prevalence and incidence worldwide

Show More
Helicobacter pylori infection may influence prevalence and disease course in MOGAD similar to MS but not AQP4-IgG associated NMOSD

Helicobacter pylori infection may influence prevalence and disease course in MOGAD similar to MS but not AQP4-IgG associated NMOSD

Show More
High level of agreement in a fixed vs live cell-based assay for antibodies to MOG in a real-world clinical laboratory setting

High level of agreement in a fixed vs live cell-based assay for antibodies to MOG in a real-world clinical laboratory setting

Show More
Investigating the association between neoplasms & MOGAD

Investigating the association between neoplasms & MOGAD

Show More
Pathology of MOGAD: A comparison with MS and AQP4+ NMOSD

Pathology of MOGAD: A comparison with MS and AQP4+ NMOSD

Show More
Pathophysiology of MOGAD

Pathophysiology of MOGAD

Show More
Pediatric MOGAD in southern China: analysis of 93 cases

Pediatric MOGAD in southern China: analysis of 93 cases

Show More
Retinal structural and microvascular changes in MOGAD & NMOSD: An OCT/OCTA study

Retinal structural and microvascular changes in MOGAD & NMOSD: An OCT/OCTA study

Show More
Transverse myelitis in MOGAD

Transverse myelitis in MOGAD

Show More
Two case reports and systematic review of the literature of adult cerebral cortical encephalitis with anti-myelin oligodendrocyte glycoprotein antibody

Two case reports and systematic review of the literature of adult cerebral cortical encephalitis with anti-myelin oligodendrocyte glycoprotein antibody

Show More

Industry Partners

Community Partners

WARNING: Internet Explorer does not support modern web standards. This site may not function correctly on this browser and is best viewed on Chrome, Firefox or Edge browsers. Learn More.